Psyence Group Inc. - 02 May 2025 SCHEDULE 13D/A Report for Psyence Biomedical Ltd. Common Shares, without par value

Filing Manager: Psyence Group Inc.
Reporting Manager: Psyence Group Inc.
Security: Psyence Biomedical Ltd. Common Shares, without par value
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Filing time: 12 May 2025, 16:08:16 UTC
Date of event: 02 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Psyence Group Inc.	0%	0	0	0	/s/ Adri Both	Adri Botha/CEO	0002009573